Financials
Income statement
Fiscal date | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 |
---|---|---|---|---|
Total reported revenue | 1.7B | 1.6B | 1.7B | 1.5B |
Cost of revenue | 539M | 496M | 481M | 443M |
Gross profit | 1.2B | 1.1B | 1.2B | 1.1B |
Operating expense | ||||
Research & development | 256M | 247M | 257M | 252M |
Selling general and admin | 543M | 525M | 562M | 546M |
Other operating expenses | — | — | — | — |
Operating income | 394M | 373M | 358M | 300M |
Non operating interest income | ||||
Income | 29M | 20M | 27M | 36M |
Expense | 21M | 12M | 15M | 16M |
Other income expense | -48M | -11M | -10M | -21M |
Pretax income | 354M | 370M | 360M | 299M |
Tax provision | 14M | 71M | 61M | 51M |
Net income | 340M | 299M | 299M | 248M |
Basic EPS | — | 1.5 | 1.5 | 1.2 |
Diluted EPS | — | 1.4 | 1.4 | 1.2 |
Basic average shares | — | 204M | 204M | 206M |
Diluted average shares | — | 208M | 210M | 212M |
EBITDA | 474M | 457M | 451M | 396M |
Net income from continuing op. | 340M | 299M | 299M | 248M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |